Galeotti C, Maddur M S, Kazatchkine M-D, Mouthon L, Kaveri S-V
Unité 872, Institut National de la Santé et de la Recherche Médicale, 75006 Paris, France.
Transfus Clin Biol. 2009 May;16(2):75-9. doi: 10.1016/j.tracli.2009.03.009. Epub 2009 May 13.
Despite their widespread use since many years in autoimmune and inflammatory disorders, the mechanisms of action of IVIg have not been completely understood. These mechanisms depend on Fc and/or F(ab')2. IVIg interacts with the different components of the immune system: Fc receptors, complement, cytokines, T and B lymphocytes, dendritic cells, granulocytes and NK cells. Here, we discuss the recent advances in the understanding of the mechanisms of action of IVIg, in particular the importance of the sialylated Fc fragment. These advances maybe help us conceive better therapeutic strategies against autoimmune and inflammatory disorders.
尽管静脉注射免疫球蛋白(IVIg)多年来在自身免疫性和炎症性疾病中被广泛使用,但其作用机制尚未完全被理解。这些机制取决于Fc和/或F(ab')2。IVIg与免疫系统的不同成分相互作用:Fc受体、补体、细胞因子、T和B淋巴细胞、树突状细胞、粒细胞和自然杀伤细胞。在此,我们讨论了对IVIg作用机制理解的最新进展,特别是唾液酸化Fc片段的重要性。这些进展可能有助于我们构思针对自身免疫性和炎症性疾病的更好治疗策略。